You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Hormonal Therapy

The guidelines and other documents available here provide recommendations related to hormonal therapy for people affected by cancer in Ontario.

Displaying Guidelines

21 Items

Pandemic Planning Clinical Guideline for Patients with Cancer

Document Status: Current
Version: 2

Dec 2021

Position Statements for Nursing Practice in Cancer Care

Document Status: Current
Version: 2

May 2021

Recombinant Humanized Thyroid Stimulating Hormone (rhTSH) Preparation Prior To Radioiodine Ablation in Patients Who Have Undergone Thyroidectomy for Papillary or Follicular Thyroid Cancer

Document Status: Archived
ID: CED 5

May 2007

Recommendations for the Delivery of Psychosocial Oncology Services in Ontario

Document Status: Current

Apr 2018

Systemic Therapy for Advanced or Recurrent Endometrial Cancer and Advanced or Recurrent Uterine Papillary Serous Carcinoma

Document Status: In-Review
ID: 4-8
Version: 4

Jul 2019

Systemic Therapy for Advanced, Recurrent, or Metastatic Uterine Sarcoma

Document Status: Archived
ID: 4-12

Nov 2012

The Role of Aromatase Inhibitors in Adjuvant Therapy for Postmenopausal Women with Hormone Receptor-positive Breast Cancer

Document Status: Archived
ID: 1-18

May 2012

The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast Cancer

Document Status: Archived
ID: 1-5

Sep 2012

The Role of HER2/neu in Systemic and Radiation Therapy for Women with Breast Cancer

Document Status: Archived
ID: 1-17

May 2012